These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24339688)

  • 61. Treatment of nasolacrimal duct obstruction in adults with polyurethane stent.
    Yazici B; Yazici Z; Parlak M
    Am J Ophthalmol; 2001 Jan; 131(1):37-43. PubMed ID: 11162977
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Repeated probing results in the treatment of congenital nasolacrimal duct obstruction.
    Singh Bhinder G; Singh Bhinder H
    Eur J Ophthalmol; 2004; 14(3):185-92. PubMed ID: 15206642
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Preloaded Monoka (Lacrijet) and congenital nasolacrimal duct obstruction: Initial results.
    Fayet B; Racy E; Ruban JM; Katowitz JA; Katowitz WR; Brémond-Gignac D
    J Fr Ophtalmol; 2021 May; 44(5):670-679. PubMed ID: 33836913
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy of probing the nasolacrimal duct with adjunctive Mitomycin-C for epiphora in adults.
    Tsai CC; Kau HC; Kao SC; Hsu WM; Liu JH
    Ophthalmology; 2002 Jan; 109(1):172-4. PubMed ID: 11772600
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Endoscopic dacryocystorhinostomy to treat congenital nasolacrimal canal dysplasia: a retrospective analysis in 40 children.
    Cui YH; Zhang CY; Liu W; Wu Q; Yu G; Li L; Wei WB
    BMC Ophthalmol; 2019 Dec; 19(1):244. PubMed ID: 31796021
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Congenital nasolacrimal duct obstruction: therapeutic management.
    Chiesi C; Guerra R; Longanesi L; Fornaciari M; Morano RP
    J Pediatr Ophthalmol Strabismus; 1999; 36(6):326-30. PubMed ID: 11132664
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Paediatric endoscopic endonasal dacryocystorhinostomy in congenital nasolacrimal duct obstruction.
    Leibovitch I; Selva D; Tsirbas A; Greenrod E; Pater J; Wormald PJ
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1250-4. PubMed ID: 16538447
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Systematic review of endoscopic-assisted surgical management for congenital nasolacrimal duct obstruction.
    Trott S; Colgrove N; Westgate P; Bush M; Iverson K
    Int J Pediatr Otorhinolaryngol; 2020 Dec; 139():110448. PubMed ID: 33091808
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of balloon dacryocystoplasty to probing as the primary treatment of congenital nasolacrimal duct obstruction.
    Gunton KB; Chung CW; Schnall BM; Prieto D; Wexler A; Koller HP
    J AAPOS; 2001 Jun; 5(3):139-42. PubMed ID: 11404738
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Outcome of Primary Probing for Simple Membraneous Congenital Nasolacrimal Duct Obstruction in Children Older Than 4 Years.
    Reynolds M; Lueder G
    J Pediatr Ophthalmol Strabismus; 2020 Jan; 57(1):44-47. PubMed ID: 31972040
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The prevalence of amblyogenic factors in children with persistent congenital nasolacrimal duct obstruction.
    Eshraghi B; Akbari MR; Fard MA; Shahsanaei A; Assari R; Mirmohammadsadeghi A
    Graefes Arch Clin Exp Ophthalmol; 2014 Nov; 252(11):1847-52. PubMed ID: 24777709
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Factors Associated With Nasolacrimal Duct Probing Failure Among Children in the Intelligent Research in Sight Registry.
    Oke I; Elze T; Miller JW; Lorch AC; Hunter DG; Elliott AT;
    JAMA Ophthalmol; 2023 Apr; 141(4):342-348. PubMed ID: 36862386
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Office probing of congenital nasolacrimal duct obstruction.
    Stager D; Baker JD; Frey T; Weakley DR; Birch EE
    Ophthalmic Surg; 1992 Jul; 23(7):482-4. PubMed ID: 1407947
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rate of Spontaneous Resolution of Congenital Nasolacrimal Duct Obstruction Prior to Scheduled Probing in Children Older Than 1 Year.
    Anhalt J; Liu GT; Weiss SJ; Wajda BN; Schnall BM
    J Pediatr Ophthalmol Strabismus; 2019 Apr; 56():e31-e33. PubMed ID: 31034086
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of age on primary balloon dacryocystoplasty and probing success in congenital nasolacrimal duct obstruction.
    Dericioğlu V; Sevik MO; Saçu SS; Eraslan M; Çerman E
    Int Ophthalmol; 2022 Nov; 42(11):3547-3554. PubMed ID: 35598226
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Success rates of primary probing for congenital nasolacrimal obstruction in children.
    Arora S; Koushan K; Harvey JT
    J AAPOS; 2012 Apr; 16(2):173-6. PubMed ID: 22525175
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Office- or Facility-Based Probing for Congenital Nasolacrimal Duct Obstruction: A Report by the American Academy of Ophthalmology.
    Morrison DG; Binenbaum G; Chang MY; Heidary G; Trivedi RH; Galvin JA; Pineles SL
    Ophthalmology; 2021 Jun; 128(6):920-927. PubMed ID: 33358412
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Probing for nasolacrimal duct obstruction with intravenous propofol sedation.
    Movaghar M; Kodsi S; Merola C; Doyle J
    J AAPOS; 2000 Jun; 4(3):179-82. PubMed ID: 10849396
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Buried Probe in Complex Congenital Nasolacrimal Duct Obstructions: Clinical Profiles and Outcomes.
    Gupta A; Kamal S; Javed Ali M; Naik MN
    Ophthalmic Plast Reconstr Surg; 2015; 31(4):318-20. PubMed ID: 25417795
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Success rates of nasolacrimal duct probing at time intervals after 1 year of age.
    Robb RM
    Ophthalmology; 1998 Jul; 105(7):1307-9; discussion 1309-10. PubMed ID: 9663238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.